Evidence map›Paper›PMID 34032883›Full record

ArticleDer Orthopade2022

[Manual addition of antibiotics to industrial bone cement mixes : Investigations of the dry mix in the cement cartridge during manual admixture to polymer-active substance mixtures].

Mustafa Citak, Stefan Luck, Philip Linke, Thorsten Gehrke, Klaus-Dieter Kühn

Abstract read
PubMed Publisher
In one paragraph

Article in Der Orthopade, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mustafa CitakAbteilung für Orthopädische Chirurgie, Helios ENDO-Klinik, Holstenstr. 2, 22767, Hamburg, Deutschland.
Stefan LuckAbteilung für Orthopädische Chirurgie, Helios ENDO-Klinik, Holstenstr. 2, 22767, Hamburg, Deutschland.
Philip LinkeAbteilung für Orthopädische Chirurgie, Helios ENDO-Klinik, Holstenstr. 2, 22767, Hamburg, Deutschland. philip.m.linke@gmail.com.
Thorsten GehrkeAbteilung für Orthopädische Chirurgie, Helios ENDO-Klinik, Holstenstr. 2, 22767, Hamburg, Deutschland.
Klaus-Dieter KühnUniversitätsklinik für Orthopädie und Traumatologie, Medizinische Universität Graz, Graz, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeriprosthetic infection (PPI) is a rare but serious complication. An elementary component of the therapy of PPI is the use of bone cement with the addition of antibiotics. For targeted therapy, manual mixing of antibiotics with industrially produced bone cement mixtures is often necessary. Possible problems resulting from manual mixing have not been described sufficiently so far.

objectivesTherefore, the aim of the present study was to describe the influence of the additional homogenisation by dry mixing of a polymer-active substance mixture on the quality of manually added cement. MATERIAL AND

methodsIn the laboratory-based study, four cement samples were prepared using different methods for manual addition and homogenisation of antibiotics (vancomycin). The reference control was Copal® G + V (Heraeus Medical GmbH, Wehrheim, Germany), to which the vancomycin (V) had already been industrially added. The samples were then examined for mechanical, microbiological and microscopic parameters.

resultsIn the mechanical and microbiological results, no statistically significant differences were found between the manually added mixtures and the reference. After dry mixing of the polymer powder, the inner surface of the mixing cartridges used showed signs of scratching in the microscopic examination and showed indications of abrasion during mixing.

conclusionThe manual addition of antibiotics to industrially produced bone cement should be reserved for selected indications if the bone cement mixtures produced by industry are not sufficient.

Indexed as

Anti-Bacterial AgentsBone CementsGermanyHumansPolymethyl MethacrylateVancomycinAnti-Bacterial AgentsBone CementsPolymethyl MethacrylateVancomycinAnti-bacterial agentsInfectionPolymethyl methacrylatePowderVancomycin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.